Hot Pursuit     19-Jul-24
Caplin Point Labs subsidiary gets US FDA nod for Ephedrine Sulfate Injection
Caplin Point Laboratories said that its subsidiary Caplin Steriles has been granted final approval from the United States Food and Drug Administration (US FDA) for its abbreviated new drug application (ANDA) for Ephedrine Sulfate Injection.

The approved ANDA is a generic therapeutic equivalent version of the reference listed drug (RLD) AKOVAZ, from Exela Pharma Sciences LLC.

Ephedrine Sulfate Injection USP is indicated for the treatment of clinically important hypotension occurring in the setting of anaesthesia.

According to IQVIA (IMS Health), Ephedrine Sulfate injection USP had US sales of approximately $36 million for the 12-month period ending May 2024.

Caplin Point Laboratories is a fast-growing pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa. The company has manufacturing facilities that cater to a complete range of finished dosage forms.

The company's consolidated net profit jumped 19.08% to Rs 121.59 crore on 16.43% increase in revenue from operations to Rs 453.22 crore in Q4 FY24 over Q4 FY23.

The scrip declined 3.59% to currently trade at Rs 1472.65 on the BSE.

Previous News
  Indices trade with major gains; pharma shares in demand
 ( Market Commentary - Mid-Session 07-Aug-24   14:33 )
  Caplin Point Laboratories fixes record date for final dividend
 ( Market Beat - Reports 07-Aug-24   13:17 )
  Caplin Steriles' Gummidipoondi unit undergoes USFDA inspection
 ( Corporate News - 01-Jun-23   19:42 )
  Caplin Point Laboratories fixes record date for interim dividend
 ( Market Beat - Reports 06-May-21   16:17 )
  Caplin Point Laboratories to hold AGM
 ( Corporate News - 10-Aug-23   10:01 )
  Caplin Point jumps after Q3 PAT rises 30% YoY to Rs 120 cr
 ( Hot Pursuit - 12-Feb-24   12:46 )
  Caplin Point Laboratories allots 11,666 equity shares under ESOP
 ( Corporate News - 12-May-22   15:35 )
  Board of Caplin Point Laboratories appoints company secretary
 ( Corporate News - 06-May-21   16:18 )
  Caplin Steriles receives USFDA approval for Labetalol Hydrochloride Injection
 ( Corporate News - 08-Sep-21   12:59 )
  Caplin Point rallies after Q1 PAT climbs 20% YoY to Rs 125 cr
 ( Hot Pursuit - 07-Aug-24   13:23 )
  Caplin Steriles receives USFDA approval for Phenylephrine hydrochloride Ophthalmic solution
 ( Corporate News - 24-May-24   12:26 )
Other Stories
  Cupid Q3 PAT jumps 25% to Rs 11 cr
  15-Feb-25   15:46
  AGS Transact Tech Q3 net loss widens to Rs 194 cr
  15-Feb-25   15:04
  Swan Energy Q3 PAT soars 406% YoY to Rs 583 cr
  15-Feb-25   12:45
  Genesys Intl Q3 PAT climbs 32% YoY to Rs 21 cr
  15-Feb-25   12:15
  PTC Industries Q3 PAT spurts 76% YoY to Rs 14 cr
  15-Feb-25   11:34
  RVNL Q3 PAT slides 13% YoY to Rs 311 crore
  15-Feb-25   10:47
  BHEL bags Rs 6,700 crore power project from Singareni Collieries
  15-Feb-25   09:48
  Mahindra & Mahindra's electric SUVs see 30,179 bookings on day 1
  15-Feb-25   09:32
  Reliance Industries acquires Lakadia B Power Transmission
  15-Feb-25   09:21
  Ethos rises after Q3 PAT climbs 15% YoY to Rs 29 cr
  14-Feb-25   15:12
Back Top